Kymera Therapeutics, Inc. KYMR
- KT-485 — Hidradenitis Suppurativa Phase 1
IRAK4 (2 companies · 2 programs)
Companies with an active program directed at IRAK4.
Nurix Therapeutics, Inc. NRIX
- NX-0479 Phase 1
Companies with an active program directed at IRAK4.